OTCMKTS:ELVAF

Evolva (ELVAF) Stock Price, News & Analysis

C$1.10
+0.24 (+28.58%)
(As of 04/1/2024)
Today's Range
C$1.10
C$1.10
50-Day Range
C$0.86
C$1.10
52-Week Range
C$0.82
C$20.00
Volume
100 shs
Average Volume
176 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
ELVAF stock logo

About Evolva Stock (OTCMKTS:ELVAF)

Evolva Holding SA discovers, researches, develops, and commercializes nature-based ingredients for use in flavor and fragrances, health ingredients, health protection, and other sectors in Switzerland, the United States, and internationally. It offers various ingredients comprising Veri-te Resveratrol, a nature made ingredient via fermentation that occurs naturally in grapes and other plants, including peanuts, cranberries, and berries; L-Arabinose, a flavoring agent used in Maillard reaction; Valencene, an aroma component of citrus fruit and citrus-derived odorants; Nootkatone, an aroma ingredient of grapefruit obtained via biochemical oxidation of valencene; and Vanillin, a primary component of vanilla bean extract. The company was founded in 2004 and is headquartered in Reinach, Switzerland.

ELVAF Stock Price History

ELVAF Stock News Headlines

Have You Seen Elon’s New A.I. Device? (Picture Inside)
A strange new era for mankind is upon us... And it's all thanks to Elon Musk's latest creation. Click here to see this strange device you could be wearing some day. Elon believes A.I. is advancing so fast...
Have You Seen Elon’s New A.I. Device? (Picture Inside)
A strange new era for mankind is upon us... And it's all thanks to Elon Musk's latest creation. Click here to see this strange device you could be wearing some day. Elon believes A.I. is advancing so fast...
Evolve Announces Changes to Risk Rating for Evolve Fund
2025 Toyota Camry Carefully Evolves
See More Headlines
Receive ELVAF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Evolva and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
OTCMKTS:ELVAF
CIK
N/A
Fax
N/A
Employees
49
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

Key Executives

  • Mr. Gerhard Lobmaier (Age 55)
    Chief Operations Officer
  • Thomas Schneckenburger C.F.A.
    Ph.D., Head of Investor & Corporate Relations
  • Philipp Frech
    General Counsel & Secretary of the Board
  • Ms. Anne De Vos (Age 60)
    Head of Sales
  • Ms. Astrid Schafer (Age 51)
    Head of Innovation
  • Dr. Luc Gruner (Age 72)
    Executive Officer

ELVAF Stock Analysis - Frequently Asked Questions

How have ELVAF shares performed in 2024?

Evolva's stock was trading at C$0.86 at the start of the year. Since then, ELVAF shares have increased by 28.6% and is now trading at C$1.10.
View the best growth stocks for 2024 here
.

How do I buy shares of Evolva?

Shares of ELVAF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:ELVAF) was last updated on 5/6/2024 by MarketBeat.com Staff

From Our Partners